UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Pharmacogenomics for immunotherapy and immune-related cardiotoxicity

Human molecular genetics, 2020-10, Vol.29 (R2), p.R186-R196

2020

Volltextzugriff (PDF)

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Nature (London), 2017-03, Vol.543 (7645), p.428-432

2017

Volltextzugriff (PDF)

PARP Inhibitor Efficacy Depends on CD8 + T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Cancer discovery, 2019-06, Vol.9 (6), p.722-737

2019

Volltextzugriff (PDF)

Comprehensive characterization of protein-protein interactions perturbed by disease mutations

Nature genetics, 2021-03, Vol.53 (3), p.342-353

2021

Volltextzugriff (PDF)

Deconvoluting cellular neighborhoods in pancreatic ductal adenocarcinoma

Communications biology, 2022-10, Vol.5 (1), p.1099-1099, Article 1099

Lal, Jessica Castrillon

2022

Volltextzugriff (PDF)

Identification of pathogenic variant enriched regions across genes and gene families

Genome research, 2020-01, Vol.30 (1), p.62

2020

Volltextzugriff (PDF)

Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?

Human molecular genetics, 2020-10, Vol.29 (R2), p.R177-R185

2020

Volltextzugriff (PDF)

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

Breast cancer research : BCR, 2021-08, Vol.23 (1), p.83-83, Article 83

2021

Volltextzugriff (PDF)

A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors

Cardio-oncology (London, England), 2021-05, Vol.7 (1), p.1-10, Article 19

2021

Volltextzugriff (PDF)

Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population

American journal of medicine open, 2023-12, Vol.10, p.100042, Article 100042

2023

Volltextzugriff (PDF)

Establishing an interdisciplinary research team for cardio-oncology artificial intelligence informatics precision and health equity

American heart journal plus, 2022-01, Vol.13, p.100094, Article 100094

2022

Volltextzugriff (PDF)

Abstract 1698: Cardiovascular adverse events associated with immune checkpoint blockade: analysis of FDA-adverse events database

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1698-1698

Castrillon, Jessica A.

2021

Volltextzugriff (PDF)

Team principles for successful interdisciplinary research teams

American heart journal plus, 2023-08, Vol.32, p.100306-100306, Article 100306

2023

Volltextzugriff (PDF)

860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A913-A913

2020

Volltextzugriff (PDF)

Abstract 11723: Defects in the Branch-Chain Amino Acid Pathway is Associated With Doxorubicin-Induced Cardiotoxicity and Preventable With a BCKDK Inhibitor or Metformin

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

The mutational landscape of the sensitivity of cancer to ionizing radiation

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3129-3129

2021

Volltextzugriff (PDF)

Network-Based Multi-Omics Approaches for Precision Cardio-Oncology: Pathobiology, Drug Repurposing and Functional Testing

Lal, Jessica Castrillon

2023

Volltextzugriff (PDF)

Machine Learning and Deep Learning in Computational Toxicology

Hong, Huixiao

1, 2023

Volltextzugriff (PDF)

Class IIa HDAC inhibition reduces breast tumors and metastases via anti-tumor macrophages

Nature (London), 2017-03, Vol.543 (7645), p.428-432

2017

Volltextzugriff (PDF)

Mapping the Radiogenome of Human Cancers

Molecular Targeted Radiosensitizers, 2020, p.35-61

2020

Volltextzugriff (PDF)

Abstract B35: Class IIa HDAC inhibition promotes an antitumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

Cancer immunology research, 2018-09, Vol.6 (9_Supplement), p.B35-B35

2018

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(12)
Female
(10)
Biomarkers
(7)
Mice
(7)
Animals
(6)
Oncology
(6)
Biochemistry & Molecular Biology
(5)
Cell Biology
(4)
Cell Line, Tumor
(4)
Genetics & Heredity
(4)
Male
(4)
Neoplasms - Genetics
(4)
Tumors
(4)
Biology
(3)
Biotechnology & Applied Microbiology
(3)
Breast Cancer
(3)
Cancer
(3)
Cancer Therapies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenomics for immunotherapy and immune-related cardiotoxicity

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

PARP Inhibitor Efficacy Depends on CD8 + T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Comprehensive characterization of protein-protein interactions perturbed by disease mutations

Deconvoluting cellular neighborhoods in pancreatic ductal adenocarcinoma

Identification of pathogenic variant enriched regions across genes and gene families

Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors

Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population

Establishing an interdisciplinary research team for cardio-oncology artificial intelligence informatics precision and health equity

Abstract 1698: Cardiovascular adverse events associated with immune checkpoint blockade: analysis of FDA-adverse events database

Team principles for successful interdisciplinary research teams

860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer

Abstract 11723: Defects in the Branch-Chain Amino Acid Pathway is Associated With Doxorubicin-Induced Cardiotoxicity and Preventable With a BCKDK Inhibitor or Metformin

The mutational landscape of the sensitivity of cancer to ionizing radiation

Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer

Network-Based Multi-Omics Approaches for Precision Cardio-Oncology: Pathobiology, Drug Repurposing and Functional Testing

Machine Learning and Deep Learning in Computational Toxicology

Abstract P5-04-01: PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing the anti-tumor potential of TAMs

Class IIa HDAC inhibition reduces breast tumors and metastases via anti-tumor macrophages

Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing the antitumor potential of TAMs

Mapping the Radiogenome of Human Cancers

Abstract B35: Class IIa HDAC inhibition promotes an antitumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

Suchergebnisse filtern